As @shermaine2000 asked, here are my thoughts about SRGA! It lacks the same liquidity of other stocks, but we can find something to guide us here. First, we have a bullish pattern today, and a pivot at 1.53 and a support at 1.32. To the side it breaks, we’ll see some very good movement next. My opinion? If it breaks up is more interesting, because the risk...
RSI Divergence and this is support by Stoch oversold and the crossover of the Stoch D & K
At bottom of sideways RSI divergence OBV, WR not good Entry 1.5 Stop 1.2 Target 5 Risk management is much more important than a good entry point. The max Risk of each plan should be less than 1% of an account. I am not a PRO trader. I trade option to test my trading plan with small cost.
Surgalign Holdings Inc is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient's lives. It markets products throughout the United...
Still long at 1.66 no sweat. Bounce off 1.57 little volume pocket. Target is still low $2 range.
I am long $SRGA at $1.65. Target $2.20 pivot Lots of insider buying. Institutional ownership way up and transactions backing it up. Long term trend reversal attempting to hold and continue. Made a very nice bounce intraday Friday and looks ready to make a move higher. Stop loss = $1.57 Target price = $2.20 Goodluck! 🤙 Follow me on ST @OneTwoThree_
SRGA has tried and failed to break/hold the 1.70 area 3 separate times suggesting it's time for the stock to start going back up. 4 of it's board members bought large sums of SRGA today totaling of 5 million altogether. I've taken a small starter position on it. Let's see where she ends up by the end of next week and reassess.
In the short term the stock has lots of resistance between $2 and $2.25. Once the stock breaks the $2.50 - $3.00 range, it could run to the upside very quickly as the stock begins to realize its hidden value. The company just did a secondary at $1.50. It is common for a stock to briefly trade lower to the price of its secondary, then rapidly turn to the...
Surgalign Holdings Inc is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver better surgical outcomes and improve patient's lives. It markets products throughout the United...
SRGA business is built around elective surgeries. As long as Covid is packing the hospitals companies like SRGA most likely will tread water. The stock will trade above $4 after the secondary closes.